You can buy or sell OCUL and other stocks, options, ETFs, and crypto commission-free!
Ocular Therapeutix, Inc. Common Stock, also called Ocular Therapeutix, is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Read More Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
52 Week High
52 Week Low
Seeking AlphaMar 7
Ocular Therapeutix (OCUL) CEO Antony Mattessich on Q4 2018 Results - Earnings Call Transcript
Ocular Therapeutix (NASDAQ:OCUL) Q4 2018 Earnings Conference Call March 7, 2019 4:30 PM ET Company Participants Antony Mattessich - President and Chief Executive Officer Donald Notman - Chief Financial Officer Scott Corning - Senior Vice President, Commercial Michael Goldstein - Chief Medical Officer Conference Call Participants Adnan Butt - Guggenheim Securities Dan Leone - Raymond James Operator Good afternoon, ladies and gentlemen, thank you for standing by. And welcome to the Ocular Therapeuti...
The Motley FoolMar 7
Ocular Therapeutix Inc (OCUL) Q4 2018 Earnings Conference Call Transcript
Ocular Therapeutix Inc (NASDAQ:OCUL) Q4 2018 Earnings Conference Call , 4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Ocular Therapeutix Fourth Quarter and Year-end 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. It is n...
Seeking AlphaFeb 25
The Story Around Ocular Therapeutix Brightens
This lifted an overhang on the stock and cleared the way for the roll-out of recently approved DEXTENZA. The shares of Ocular Therapeutix jumped 15% in trading Friday as the company entered into a debt facility with favorable terms. "Discomfort is understandable. It's the rudeness that isn't." - N.K. Jemisin, The Fifth Season Ocular Therapeutix (OCUL) had one of its best trading days in quite some time on Friday, rising some 15% on the day. The shares have been challenged like so many "Tier 3" concerns ...
Expected May 7, After Hours